News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
186,831 Results
Type
Article (17921)
Company Profile (123)
Press Release (168787)
Multimedia
Podcasts (36)
Webinars (12)
Section
Business (58395)
Career Advice (948)
Deals (9412)
Drug Delivery (37)
Drug Development (23535)
Employer Resources (72)
FDA (2388)
Job Trends (4274)
News (92548)
Policy (5817)
Tag
Academia (486)
Accelerated approval (3)
Adcomms (15)
Allergies (24)
Alliances (16314)
ALS (45)
Alzheimer's disease (481)
Antibody-drug conjugate (ADC) (108)
Approvals (2340)
Artificial intelligence (138)
Autoimmune disease (23)
Automation (6)
Bankruptcy (83)
Best Places to Work (2893)
BIOSECURE Act (19)
Biosimilars (40)
Biotechnology (111)
Bladder cancer (45)
Brain cancer (15)
Breast cancer (131)
Cancer (1176)
Cardiovascular disease (80)
Career advice (769)
Career pathing (21)
CAR-T (124)
CDC (4)
Cell therapy (331)
Cervical cancer (10)
Clinical research (19206)
Collaboration (546)
Company closure (2)
Compensation (157)
Complete response letters (13)
COVID-19 (763)
CRISPR (32)
C-suite (210)
Cystic fibrosis (48)
Data (1124)
Denatured (5)
Depression (26)
Diabetes (85)
Diagnostics (1092)
Digital health (3)
Diversity (2)
Diversity, equity & inclusion (21)
Drug discovery (77)
Drug pricing (29)
Drug shortages (2)
Duchenne muscular dystrophy (59)
Earnings (16365)
Editorial (19)
Employer branding (8)
Employer resources (69)
Events (32182)
Executive appointments (475)
FDA (2849)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (2)
Frontotemporal dementia (7)
Funding (479)
Gene editing (74)
Generative AI (14)
Gene therapy (241)
GLP-1 (303)
Government (665)
Grass and pollen (1)
Guidances (45)
Healthcare (2401)
Huntington's disease (23)
IgA nephropathy (23)
Immunology and inflammation (103)
Immuno-oncology (10)
Indications (14)
Infectious disease (832)
Inflammatory bowel disease (78)
Inflation Reduction Act (3)
Influenza (27)
Intellectual property (56)
Interviews (140)
IPO (4152)
IRA (14)
Job creations (1478)
Job search strategy (704)
Kidney cancer (7)
Labor market (35)
Layoffs (202)
Leadership (15)
Legal (1201)
Liver cancer (21)
Lung cancer (138)
Lymphoma (104)
Machine learning (5)
Management (23)
Manufacturing (198)
MASH (34)
Medical device (686)
Medtech (687)
Mergers & acquisitions (5553)
Metabolic disorders (299)
Multiple sclerosis (45)
NASH (8)
Neurodegenerative disease (69)
Neuropsychiatric disorders (16)
Neuroscience (779)
NextGen: Class of 2025 (1451)
Non-profit (456)
Now hiring (23)
Obesity (163)
Opinion (181)
Ovarian cancer (47)
Pain (39)
Pancreatic cancer (50)
Parkinson's disease (79)
Partnered (10)
Patents (107)
Patient recruitment (54)
Peanut (15)
People (22509)
Pharmaceutical (16)
Phase I (7454)
Phase II (9186)
Phase III (5145)
Pipeline (657)
Policy (95)
Postmarket research (306)
Preclinical (3074)
Press Release (61)
Prostate cancer (40)
Psychedelics (19)
Radiopharmaceuticals (87)
Rare diseases (228)
Real estate (2446)
Recruiting (36)
Regulatory (4683)
Reports (22)
Research institute (519)
Resumes & cover letters (153)
Rett syndrome (4)
RNA editing (8)
RSV (14)
Schizophrenia (26)
Series A (108)
Series B (66)
Service/supplier (6)
Sickle cell disease (25)
Special edition (12)
Spinal muscular atrophy (50)
Sponsored (13)
Startups (1794)
State (1)
Stomach cancer (6)
Supply chain (26)
Tariffs (27)
The Weekly (31)
Vaccines (268)
Venture capital (49)
Weight loss (99)
Women's health (11)
Worklife (8)
Date
Last 7 days (145)
Last 30 days (690)
Last 365 days (11774)
2025 (6492)
2024 (12647)
2023 (13201)
2022 (16037)
2021 (16924)
2020 (13174)
2019 (9492)
2018 (7536)
2017 (8976)
2016 (8112)
2015 (9408)
2014 (9724)
2013 (9449)
2012 (6079)
2011 (6451)
2010 (5840)
Location
Africa (328)
Alabama (38)
Alaska (3)
Arizona (53)
Arkansas (2)
Asia (13717)
Australia (2714)
California (2849)
Canada (861)
China (266)
Colorado (50)
Connecticut (112)
Delaware (60)
Europe (30776)
Florida (332)
Georgia (47)
Hawaii (1)
Idaho (13)
Illinois (163)
India (13)
Indiana (137)
Iowa (5)
Japan (92)
Kansas (18)
Kentucky (5)
Louisiana (5)
Maine (2)
Maryland (393)
Massachusetts (2222)
Michigan (84)
Minnesota (140)
Mississippi (1)
Missouri (18)
Montana (8)
Nebraska (4)
Nevada (14)
New Hampshire (7)
New Jersey (705)
New Mexico (11)
New York (712)
North Carolina (440)
North Dakota (6)
Northern California (1221)
Ohio (64)
Oklahoma (7)
Oregon (9)
Pennsylvania (560)
Puerto Rico (5)
Rhode Island (12)
South America (402)
South Carolina (3)
Southern California (1119)
Tennessee (24)
Texas (350)
United States (9704)
Utah (39)
Virginia (23)
Washington D.C. (18)
Washington State (392)
West Virginia (1)
Wisconsin (17)
186,831 Results for "moleculin biotech".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Moleculin Expands Phase 3 MIRACLE Clinical Trial into the Country of Georgia, Enrollment Update and Future Plans
July 10, 2025
·
8 min read
Lone Star Bio
Moleculin to Present at the MedInvest Biotech & Pharma Investor Conference
Moleculin Biotech, Inc., (Nasdaq: MBRX) (Moleculin or the Company) today announced Walter Klemp, President and Chief Executive Officer of Moleculin will present at the MedInvest Biotech & Pharma Investor Conference behind held in New York City, NY on Thursday, April 4, 2024 at 4:10 PM ET.
March 28, 2024
·
2 min read
Press Releases
Moleculin Receives Positive FDA Feedback on Pediatric Study Plan for Annamycin in Children with R/R AML
June 19, 2025
·
7 min read
Press Releases
Moleculin Reports First Quarter 2025 Financial Results and Provides Corporate Update
May 15, 2025
·
13 min read
Press Releases
Moleculin Receives European Medicines Agency Approval to Expand Phase 3 MIRACLE Clinical Trial
May 12, 2025
·
8 min read
Press Releases
Moleculin Announces World Health Organization Approval of “naxtarubicin” as International Non-Proprietary Name for Annamycin
May 7, 2025
·
6 min read
Press Releases
Moleculin Bolsters Annamycin Intellectual Property Portfolio with Granting of Two New U.S. Patents
May 5, 2025
·
5 min read
Lone Star Bio
Moleculin to Participate in the Virtual Investor Lunch Break: The Moleculin Opportunity
Moleculin Biotech, Inc. announced that it will present at the Virtual Investor Lunch Break: The Moleculin Opportunity event on Thursday, March 28, 2024 at 12:00 PM ET.
March 27, 2024
·
2 min read
Press Releases
Moleculin to Report First Quarter 2025 Financial Results on May 13, 2025 and Host Conference Call and Webcast
May 7, 2025
·
4 min read
Pharm Country
Moleculin Biotech (NASDAQ:MBRX) Participates in Virtual Investor “What This Means” Segment Hosted by JTC Team
JTC Team (“JTC”), a fully integrated corporate communications and investor relations firm, today released a Virtual Investor “What This Means” segment featuring Moleculin Biotech (NASDAQ:MBRX), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting hard-to-treat tumors and viruses.
April 25, 2024
·
1 min read
1 of 18,684
Next
